Ask for high quality link by putting your email below

Please, double check your email!

How to make in vitro models predictive of in vivo conditions?

  • By taking into account the 3D cellular organization of in vivo tissues
  • By including the cellular and matricial microenvironments with BIOMIMESYS®
  • By using OoC systems for dynamic in vivo-like in vitro systems

Dynamic models hold promise for future predictive microphysiological systems (MPS). By combining BIOMIMESYS® as an ECM surrogate for 3D culture, and hiPSC-derived cells, these dynamic microfluidic systems will revolutionize the field, reproducing human tissues and predict human outcomes.

Grégory MAUBON

Grégory MAUBON is Chief Data Officer and digital coordinator at HCS Pharma, a biotech startup focused in high content screening and complex diseases. He manages IT missions and leads digital usages linked to company needs. He is also a Augmented Reality Evangelist (presenter and lecturer) since 2008, where he created and founded in 2010 RA'pro (the augmented reality promotion association). He helped many companies (in several domains) to define precisely their augmented reality needs and supported them in the implementation.

1 Comment

HCS Pharma était présent au Workshop OoC 2022 (article in french) - HCS Pharma · March 8, 2022 at 1:55 pm

[…] stand et notre poster (lien ici) associé nous ont permis d’attirer de nombreux curieux, et de nouer de précieux contacts […]

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.